Charlie is a founding partner and Managing Director of NewHold Enterprises, having spent more than 20 years in private equity and principal investing both as a legal advisor and as an investor. Prior to NewHold Enterprises, Charlie was also a founding Partner of River Hollow Partners, where he had was lead partner on several consumer products and business services investments focused on health and wellness.
Charlie has extensive experience working with portfolio companies on acquisitions and divestures, commercial contracts, consolidation strategies, debt financing and refinancing, capital markets and exit strategies through private sales, public mergers and IPOs. He also has comprehensive knowledge of core legal and regulatory considerations relating to both domestic as well as complex cross border transactions and his sector experience includes companies focusing on consumer products, logistics, business services, real estate, diversified industrials, renewable energy and financial services.
Qualifying as a lawyer in the UK in 2001 with Simmons & Simmons in the Corporate Finance Group, he worked in London and Tokyo before moving to Minter Ellison in Sydney to the M&A team. He joined Macquarie in 2005, working primarily on principal acquisitions, based initially in Sydney. In 2007 he relocated to Macquarie’s New York office, where he focused on principal investments and capital markets transactions across multiple jurisdictions, before becoming a Founding Partner of River Hollow Partners in early 2014, and subsequently NewHold Enterprises in 2017.
Charlie received his LLB Hons degree in Business Law from City University, London and is dual qualified as an English lawyer and a member of the New York Bar.
Charlie currently serves as the Chairman of Macro Energy, is on the Board of NewHold AEC Corp., Powerful Foods LLC and is a Board observer for Luna Pharmaceuticals, Inc.
Charlie is joining McCormack Innovation as a Special Advisors and North American representative and brings a wealth of experience to the team. “I am very excited to have the opportunity to partner with McCormack Innovation to bring their unique range of products to markets around the world, both for medical and general consumer applications. What Brian and Garry have been able to achieve to date is nothing short of remarkable and their dedication and focus on solving problems and developing solutions which will have long standing environmental and health benefits is inspiring.”
Brian McCormack said: “We are extremely happy that Charlie has joined the McCormack team and brings with him a wealth of experience in bringing products to market and navigating commercial and business issues to establish successful and enduring commercial partnerships around the world. His combination of legal and commercial experience will be a real asset for McCormack Innovation.”
